Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Immunovant, Inc. | 137,251 | reported | 01 Apr 2025 | tx 18+321,961−12,700 |
| ABEONA THERAPEUTICS INC. | 37,954 | reported | 17 Jun 2020 | tx 2+83,520 |
| REGENXBIO Inc. | 19,054 | reported | 30 May 2025 | tx 9+136,539 |
| Dimension Therapeutics, Inc. | 0 | reported | 07 Nov 2017 | tx 5+49,069−104,841 |
| IGEN INTERNATIONAL INC /DE | 0 | reported | 13 Feb 2004 | tx 17+42,402−307,467 |
| BIOVERIS CORP | 0 | reported | 26 Jun 2007 | tx 29+319,430−589,795 |
| DYAX CORP | 0 | reported | 22 Jan 2016 | tx 85+2,162,124−2,293,624 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 May 2025 | GRANT_AWARD | REGENXBIO Inc. | 7,768 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | REGENXBIO Inc. | 39,815 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 16,188 | 0.00 USD | |
| 01 Apr 2025 | GRANT_AWARD | Immunovant, Inc. | 7,600 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | REGENXBIO Inc. | 4,790 | 0.00 USD | |
| 31 May 2024 | GRANT_AWARD | REGENXBIO Inc. | 24,454 | 0.00 USD | deriv |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 11,255 | 0.00 USD | |
| 02 Apr 2024 | GRANT_AWARD | Immunovant, Inc. | 4,690 | 0.00 USD | deriv |
| 01 Dec 2023 | SALE | Immunovant, Inc. | 3,478 | 39.81 USD | |
| 01 Dec 2023 | SALE | Immunovant, Inc. | 4,200 | 38.79 USD | |
| 01 Dec 2023 | SALE | Immunovant, Inc. | 5,022 | 40.46 USD | |
| 02 Jun 2023 | GRANT_AWARD | REGENXBIO Inc. | 3,486 | 0.00 USD | |
| 02 Jun 2023 | GRANT_AWARD | REGENXBIO Inc. | 17,892 | 0.00 USD | deriv |
| 12 Apr 2023 | GRANT_AWARD | Immunovant, Inc. | 12,523 | 0.00 USD | |
| 12 Apr 2023 | GRANT_AWARD | Immunovant, Inc. | 16,260 | 0.00 USD | deriv |
| 17 Aug 2022 | GRANT_AWARD | Immunovant, Inc. | 21,059 | 0.00 USD | |
| 17 Aug 2022 | GRANT_AWARD | Immunovant, Inc. | 31,668 | 0.00 USD | deriv |
| 03 Jun 2022 | GRANT_AWARD | REGENXBIO Inc. | 3,010 | 0.00 USD | |
| 03 Jun 2022 | GRANT_AWARD | REGENXBIO Inc. | 15,324 | 0.00 USD | deriv |
| 10 Jan 2022 | GRANT_AWARD | Immunovant, Inc. | 21,726 | 0.00 USD | |
| 10 Jan 2022 | GRANT_AWARD | Immunovant, Inc. | 71,492 | 0.00 USD | deriv |
| 03 Sept 2021 | GRANT_AWARD | REGENXBIO Inc. | 20,000 | 0.00 USD | deriv |
| 20 Aug 2021 | PURCHASE | Immunovant, Inc. | 7,000 | 7.65 USD | first after silenceanomaly |
| 19 Mar 2021 | GRANT_AWARD | Immunovant, Inc. | 15,500 | 0.00 USD | |
| 19 Mar 2021 | GRANT_AWARD | Immunovant, Inc. | 23,300 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 20 Aug 2021.